Columbus, OH (PRWEB) July 14, 2014
Vaginal Mesh lawsuit claims continue to mount as litigation continues against seven different pelvic mesh manufacturers in the U.S. District Court, Southern District of West Virginia notes Wright & Schulte LLC. The federal complaints are pending against pelvic mesh manufacturers that include Ethicon, Inc. (MDL No. 2327), American Medical Systems (MDL No. 2325), and C.R. Bard, Inc., (MDL No. 2187). As of June 16th, there are 58,262 Vaginal Mesh lawsuit claims pending, according to statistics from the U.S. Judicial Panel on Multidistrict Litigation. The bladder mesh lawsuits all allege that the women experienced serious injuries, including pain during sexual intercourse, mesh erosion, and bleeding after having the mesh surgically implanted to either treat pelvic organ prolapse or to treat stress urinary incontinence. In addition, the bladder mesh lawsuits contend that the manufacturers neglected to adequately test the safety of their vaginal mesh slings, and also knew or should have known about the derious health risks associated with bladder mesh slings and that they did not properly warn the public of the serious side-effects associated with vaginal mesh implants.
The attorneys at Wright & Schulte LLC are currently representing women in Vaginal Mesh lawsuit claims who have experienced serious side-effects purportedly from pelvic mesh implants and have undergone revision surgery. If you believe you have experienced serious side-effects from transvaginal mesh or bladder mesh contact the firm at 1800-399-0795 or visit http://www.yourlegalhelp.com for more information. You can also like us on Facebook and follow us on Twitter for all the updated news.
According to court records for these Vaginal Mesh Lawsuits involving seven different manufactuers, Ethicon Inc. has the largest number of complaints pending in federal litigation, with a total of 18,176. American Medical Systems, Inc., follows with 17,821 lawsuits. A total of 12,004 complaints have been filed against Boston Scientific Corp. (In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation (MDL No. 2326). Also pending are 8,555 lawsuits against C.R. Bard, Inc., and 1,468 complaints against Coloplast Corp. (In Re: Coloplast Corp. Pelvic Support System Products Liability Litigation, MDL No. 2387). There are far fewer lawsuits pending in the remaining litigation. For instance, there are 195 complaints pending against Cook Medical Inc. (In Re Cook Medical, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2440), and 52 lawsuits pending against Neomedic Pelvic Repair System Products (MDL 2511). In addition to experiencing complications from using the device, the complaints further purport that women had to undergo multiple surgeries to have the pelvic devices removed.
Court records additionally show litigation is pending in Superior Court of New Jersey, Atlantic County, against two vaginal mesh manufacturers that are involved in the federal litigation. As of June 16, 2014, C.R. Bard Inc. has 1,379 complaints pending in the state court. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10) In the second consolidated litigation, Ethicon Inc. has 5,060 vaginal mesh lawsuits pending (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10)
[jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-16-2014.pdf, June 16, 2014]
According to the U.S. Food & Drug Administration (FDA), the surgical mesh devices support the bladder, uterus and bowel when they become so weak that they drop from their normal position and bulge (prolapse) into the vagina. The FDA issued warnings in 2008 and 2011 about the transvaginal mesh after receiving reports from women complaining of mesh erosion, vaginal scarring, pain and other complications. Due to continued complaints, the regulatory agency in April 2014, called for a reclassification of transvaginal mesh from a “moderate risk” device to a “high-risk” device. The FDA explained that moderate risk devices are eligible for the agency’s 510(k) clearance process, which means a manufacturer is not required to conduct human clinical trials of a product before its sold on the market. Under the FDA’s proposal, reclassifying transvaginal mesh as a high-risk device means manufacturers are now required to conduct human clinical trials and provide clinical data about the safety and effectiveness of the device if they want to continue selling their product.
[fda.gov/newsevents/newsroom/pressannouncements/ucm395192.htm, April 29, 2014]
[fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm, July 13, 2011]
Bloomberg reported that one day after the FDA's announcement on its proposal to reclassify the mesh device, Endo International announced it would settle about 22,000 lawsuits against its American Medical Systems Inc., subsidiary over pelvic mesh devices. According to Bloomberg, women who alleged injuries due to the surgical mesh implants will receive an average of $40,000 per case, but those who had more severe injuries and had multiple surgeries to have the implants remove can seek more for their claims. The news agency also reported that the Denmark-based Coloplast agreed in March to pay $16 million to resolve 400 claims. The settlement averages to about $40,000 for each woman in those claims, the report said.
[bloomberg.com/news/2014-04-30/endo-pays-830-million-to-resolve-vaginal-mesh-suits.html., May 1, 2014]
About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.
Read the full story at http://www.prweb.com/releases/2014/07/prweb12012383.htm.
Copyright©2014 Vocus, Inc.
All rights reserved